NPCE logo

NPCE

Neuropace Inc.

$16.19
-$0.16(-0.98%)
51
Overall
40
Value
63
Tech
--
Quality
Market Cap
$464.98M
Volume
58.77K
52W Range
$7.56 - $18.98
Target Price
$19.25

Company Overview

Mkt Cap$464.98MPrice$16.19
Volume58.77KChange-0.98%
P/E Ratio-17.1Open$16.35
Revenue$79.9MPrev Close$16.35
Net Income$-27.1M52W Range$7.56 - $18.98
Div YieldN/ATarget$19.25
Overall51Value40
Quality--Technical63

No chart data available

About Neuropace Inc.

NeuroPace, Inc. operates as a medical device company in the United States. The company develops RNS system, a brain-responsive neuromodulation system that delivers personalized, real-time treatment at the seizure source for treating drug-resistant focal epilepsy. It also records continuous brain activity data and enables clinicians to monitor patients in person and remotely. Its RNS System includes RNS neurostimulator, cortical strip and depth leads, and Patient Remote Monitor, as well as other implantable and non-implantable accessories. In addition, the company provides Physician Tablet, Patient Data Management System, and nSight Platform, which facilitates ongoing patient monitoring and streamlines patient support. It sells its products to hospital facilities for initial RNS System implant procedures and for replacement procedures. NeuroPace, Inc. was incorporated in 1997 and is headquartered in Mountain View, California.

Sector: Manufacturing
Industry: Surgical and Medical Instrument Manufacturing

Latest News

Lake Street Keeps Their Buy Rating on NeuroPace (NPCE)

In a report released today, Frank Takkinen from Lake Street reiterated a Buy rating on NeuroPace, with a price target of $20.00. Takkinen covers th...

TipRanks Auto-Generated Intelligence Newsdesk9 days ago

Wells Fargo Sticks to Their Buy Rating for NeuroPace (NPCE)

TipRanks Auto-Generated Intelligence Newsdesk14 days ago

UBS Keeps Their Buy Rating on NeuroPace (NPCE)

TipRanks Auto-Generated Intelligence Newsdesk17 days ago

Analysts Offer Insights on Healthcare Companies: NeuroPace (NPCE) and Evaxion Biotech (EVAX)

Catie Powers18 days ago
ABCD
1SymbolPriceChangeVol
2NPCE$16.19-1.0%58.77K
3
4
5
6

Get Neuropace Inc. Data in Excel

Stream real-time data directly to your spreadsheets

BUY NOW
Stock data provided by MarketXLS.